Today Lonza announced the release of a new e-Learning Module for its QC Insider™ Toolbox, “Overcoming Interference,” which covers the causes of interference in the Bacterial Endotoxins Test (BET) and provides the user with solutions to help ensure compliance.

Being able to overcome the inhibitory or enhancing properties of a sample is required by the BET monograph, the validation of which forms part of the test for the final product release of injectable drugs and medical devices. Many of the pharmaceutical products that are either in use or being developed today have characteristics that cause them to interfere with the BET.

Katrin Hoeck, Head of Marketing Analysis and Testing at Lonza Bioscience Solutions explains: “Some components of a test solution can interfere with the BET assay. Pre-treatment of samples is an important aspect in overcoming interference as a simple dilution will usually solve the issue; however, our new e-Learning Module helps QC professionals respond to situations when dilution alone is not sufficient to overcome interference.”

The e-Learning Modules, launched in January 2016 as part of the QC Insider™ Toolbox, are a suite of online endotoxin training courses designed to deliver the technical knowledge that Quality Control professionals need to achieve success with BET. Each interactive module can be taken at the user’s convenience; and, upon completion of a Knowledge Test, the learner will receive a Certificate of Completion for their training records.

more about lonza